Stay updated on Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.

Latest updates to the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision entry v3.5.4 was added to the Record History, and the previous revision v3.5.3 was removed, indicating the page has been updated to the latest version.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedA system/library version label on the page footer was updated from Revision v3.5.2 to Revision v3.5.3, with no corresponding changes to the clinical trial record history or displayed study details.SummaryDifference0.1%

- Check40 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded revision: v3.5.0 to the history. Deleted revision: v3.4.3 from the history.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed, reflecting an administrative update to the page history rather than any study content changes.SummaryDifference0.1%

- Check105 days agoChange DetectedThe record history shows a minor revision update from v3.4.1 to v3.4.2; there are no changes to study data, design, or substantive content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.